Latest Regulatory Approval News

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.

Vault Minerals Limited has announced a significant security consolidation, reducing its ordinary shares and performance rights by a factor of more than six. The move, effective from mid-November, aims to streamline the company’s capital structure ahead of resumed trading.

Prominence Energy has achieved a pivotal milestone with the award of Petroleum Exploration Licence 803 for its Gawler Hydrogen Project, positioning itself as a key player in Australia's emerging natural hydrogen sector. The company also strengthened its leadership team and completed a $1.75 million capital raise to fund its growth ambitions.

Iluka Resources has withdrawn its synthetic rutile sales guidance due to uncertainties stemming from Venator's sale and idling of its Greatham titanium dioxide facility. The move highlights growing market challenges and contract renegotiations in the pigment sector.

Tivan Limited has received regulatory clearance to begin drilling at its Sandover Fluorite Project, aiming to unlock high-grade fluorite deposits with assays reaching 94% CaF2. The staged drilling program marks a significant step toward defining a commercially viable resource.

The ASX has granted key waivers allowing Southern Cross Media to proceed with its acquisition of Seven West Media without shareholder approval, smoothing the way for a major media consolidation.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.

Talga Group and SQM have mutually terminated their joint venture for the Aero Project in Sweden due to regulatory delays, with Talga now exploring new partnership opportunities to advance the critical minerals project.

Santana Minerals has taken a major step forward by acquiring freehold ownership of critical lands and extinguishing royalties at its Bendigo-Ophir Gold Project, enhancing project economics amid a strong gold market.

Firebrick Pharma has secured a $102,000 investment from its Philippines strategic partner, Pharma Nutria N.A., Inc., reinforcing its position ahead of the Nasodine nasal spray launch in 2026.

Anteris Technologies has secured its first European regulatory clearance to commence the global PARADIGM Trial for its DurAVR Transcatheter Heart Valve, marking a significant step toward worldwide commercialization.

Clarity Pharmaceuticals has inked a pivotal supply agreement with Nusano to ensure a steady source of copper-67, a critical isotope for its upcoming Phase III prostate cancer trial and future commercialisation plans.